Elevated levels of S100A8 and S100A12 are considered a potential biomarker of sepsis in human patients, and their levels of expression have been associated with poor disease outcomes (Payen et al., 2008; Dubois et al., 2019; Sehgal et al., 2022). The gene discussed is S100A12; the disease is Sepsis.